Human CD274 (Programmed Cell Death 1 Ligand 1) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-05887P

SDS-PAGE analysis of Human CD274 (Programmed Cell Death 1 Ligand 1) - Recombinant Protein, CAT# BLT-05887P, showing >90% purity under 15% SDS-PAGE (Reduced)
Human CD274 (Programmed Cell Death 1 Ligand 1) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-05887P
Regular price
$59500
$595.00
Sale price$47500
$475.00Save $120
/
Quantity Pricing
Pack Size | Price (USD) |
---|---|
500 µg | $1,100 (Summer Promotion) |
1 mg | $1,990 (Summer Promotion) |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
Product Name | Recombinant Human PD-L1 / B7-H1 / CD274 Protein |
Product Overview | This recombinant human PD-L1 / B7-H1 / CD274 protein includes amino acids 1-239aa of the MAPT gene is expressed in HEK293 Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id | Q9NZQ7 |
Recommended Name | Programmed cell death 1 ligand 1 |
Gene Name | CD274 |
Synonyms | B7-H;B7-H1;B7H1;PD-L1;PDCD1L1;PDCD1LG1;PDL1 |
Species | Human |
Predicted Molecular Mass | 26.8 kDa |
Expression System | Mammalian Cell |
Expression Range | 1-239aa |
Tag | C-His |
Purity | >90% |
Formulation | Lyophilized |
Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications | Positive Control; Immunogen; SDS-PAGE; WB |
Research Area | Cancer |
Target Function | Plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response. Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10).; The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, thereby facilitating tumor survival. The interaction with PDCD1/PD-1 inhibits cytotoxic T lymphocytes (CTLs) effector function. The blockage of the PDCD1-mediated pathway results in the reversal of the exhausted T-cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy. |
Subcellular Location | Cell membrane; Single-pass type I membrane protein. Early endosome membrane; Single-pass type I membrane protein. Recycling endosome membrane; Single-pass type I membrane protein.; [Isoform 1]: Cell membrane; Single-pass type I membrane protein.; [Isoform 2]: Endomembrane system; Single-pass type I membrane protein. |
Protein Family | Immunoglobulin superfamily, BTN/MOG family |
Tissue Specificity | Highly expressed in the heart, skeletal muscle, placenta and lung. Weakly expressed in the thymus, spleen, kidney and liver. Expressed on activated T- and B-cells, dendritic cells, keratinocytes and monocytes. |